Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ELI LILLY AND COMPANY

(LLY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Eli Lilly and Company
Eli Lilly and Company is a drug manufacturing company. The Company discover, develop, manufacture, and market products in a human pharmaceutical product segment. The Company’s products include Diabetes and other endocrinology products, including Baqsimi, Basaglar, Forteo, Humalog, Humatrope, Humulin, Jardiance, Trajenta and Trulicity. Its Immunology products include Olumiant and Taltz. Its Neuroscience products include Cymbalta, Emgality, Reyvow, Strattera and Zyprexa. Its Oncology products include Alimta, Cyramza, Erbitux and Verzenio. Other product includes Cialis, for the tratment of erectile dysfunction and benign prostatic hyperplasia. The Company manufacture and distribute its products through facilities in the United States, Puerto Rico, and 8 other countries. Its products are sold in approximately 120 countries.

Number of employees : 35 000 people.
Sales per Business
20192020Delta
Pharmaceutical Products22 319.50100%24 539.80100% +9.95%
USD in Million
Sales per region
2020
United States14 229.3058%
Europe4 187.7017.1%
Japan2 583.1010.5%
Other Foreign Countries2 422.709.9%
China1 116.904.6%
USD in Million
Managers
Name Title Age Since
David Ricks Chairman, President & Chief Executive Officer 52 2017
Anat Ashkenazi Chief Financial Officer & Senior Vice President 47 2021
Timothy Garnett Chief Medical Officer & VP-Global Medical - 1998
Daniel Skovronsky Chief Scientific Officer & Senior Vice President 46 -
Diogo Rau Senior VP, Chief Information & Digital Officer - 2021
Alonzo Weems Senior VP, Chief ethics & Compliance Officer - 2021
Jon Erik Fyrwald Independent Director 62 2005
Michael L. Eskew Independent Director 70 2008
Ralph Alvarez Independent Director 65 2009
Katherine Baicker, Dr. Independent Director 48 2011
Members of the board
Name Title Age Since
David Ricks Chairman, President & Chief Executive Officer 52 2017
Jon Erik Fyrwald Independent Director 62 2005
Michael L. Eskew Independent Director 70 2008
Ralph Alvarez Independent Director 65 2009
Katherine Baicker, Dr. Independent Director 48 2011
William G. Kaelin, Dr. Independent Director 62 2012
Marschall S. Runge, Dr. Independent Director 65 2013
Jackson Peter Tai Independent Director 69 2013
Juan Luciano Lead Independent Director 58 2019
Jamere Jackson Independent Director 51 2016
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 957,043,893 955,115,236 99.8% 463,000 0.0% 99.8%
Shareholders
NameEquities%
Capital Research & Management Co. 109,033,091 11.4%
Lilly Endowment, Inc. 108,248,610 11.3%
The Vanguard Group, Inc. 65,549,864 6.85%
The PNC Financial Services Group, Inc. 52,012,151 5.44%
PNC Bank, NA (Investment Management) 51,574,475 5.39%
PRIMECAP Management Co. 33,959,267 3.55%
SSgA Funds Management, Inc. 32,927,576 3.44%
Wellington Management Co. LLP 30,530,168 3.19%
Fidelity Management & Research Co. LLC 28,251,186 2.95%
T. Rowe Price Associates, Inc. (Investment Management) 26,739,216 2.80%
Holdings
NameEquities%Valuation
DICERNA PHARMACEUTICALS, INC. (DRNA) 5,414,185 6.97% 111,423,927 USD
IMMUNOCORE HOLDINGS PLC 2,548,145 6.25% 88,063,891 USD
AVIDITY BIOSCIENCES, INC. (RNA) 2,319,396 5.08% 52,975,005 USD
PRECISION BIOSCIENCES, INC. (DTIL) 3,762,190 6.31% 47,290,728 USD
PROQR THERAPEUTICS N.V. (PRQR) 3,989,976 6.23% 26,653,040 USD
SIGILON THERAPEUTICS, INC. (SGTX) 2,744,443 8.56% 16,301,991 USD
NEXTCURE, INC. (NXTC) 2,088,859 7.57% 15,917,106 USD
LEAP THERAPEUTICS, INC. (LPTX) 1,819,758 3.05% 3,129,984 USD
AC IMMUNE SA (ACIU) 0 0.0000%
Markets and indexes
- International Market
- S&P 100 / S&P 500, Stoxx Americas 100, Stoxx Global 200
Stock Exchange Codes
- Bloomberg Code :  LILY11B:BZ
- Reuters Code :  
- Datastream Code :  
Company contact information
Eli Lilly and Company
Lilly Corporate Center
IN 46285 Indianapolis, Indiana

Phone : +1 617-225-3226
Fax :
web site : https://investor.lilly.com/
Brand Portfolio
In partnership withAllbrands.markets
More brands of Eli Lilly and Company
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
ELI LILLY AND COMPANY36.28%208 604
JOHNSON & JOHNSON4.68%433 701
ROCHE HOLDING AG10.97%321 442
PFIZER, INC.19.23%246 078
NOVO NORDISK A/S50.80%232 556
ABBVIE INC.0.54%190 378
NOVARTIS AG-7.42%186 081
MERCK & CO., INC.-12.37%181 449
ASTRAZENECA PLC10.09%171 794
BRISTOL-MYERS SQUIBB COMPANY-1.16%136 238
AMGEN INC.-4.58%124 575
SANOFI3.62%120 158
GLAXOSMITHKLINE PLC3.44%95 560
ALLERGAN PLC0.97%63 659
CHUGAI PHARMACEUTICAL CO., LTD.-23.73%62 799
TAKEDA PHARMACEUTICAL COMPANY LIMITED1.54%54 566
BAYER AG-6.12%52 137
DAIICHI SANKYO COMPANY, LIMITED-20.66%48 910
JIANGSU HENGRUI MEDICINE CO., LTD.-49.45%46 272
ASTELLAS PHARMA INC.18.51%31 855
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY49.98%24 783